Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1006 results for "aurobindo"

Good Timing

Three pharma companies to focus on

Aurobindo Pharma, Glenmark and Natco are companies witnessing strong traction in both domestic and international arena Business Standard, 3 days ago
Good Timing, 1 week ago

153 images for aurobindo

The Freepress Journal, 1 week ago, 2 days ago, 1 week ago
Money Control, 2 weeks ago
Money Control, 2 weeks ago, 3 weeks ago, 2 weeks ago
Financial Express, 2 weeks ago
Financial Express, 2 weeks ago, 2 weeks ago
Money Control

Top buzzing midcap stocks to trade on October 18

Here are a few top buzzing midcap stocks picked up by CNBC-TV18's analysts in trade today. We have - Aurobindo Pharma, Arvind, Shriram EPC, PNB, ICICI Bank, Gujarat Pipavav, Zensar, Aarti Drugs, Aarti Industries, and Indian Hume.
 Money Control4 days ago Sensex, Nifty open in green; Axis drags, Reliance Aurobindo up  Money Control2 weeks ago Buy, sell or hold: Watch out for these 11 stocks today  Money Control2 weeks ago Aurobindo Pharma, EIL, Maruti likely to be in focus today  Money Control1 month ago

Buy Aurobindo Pharma, Snowman Logistics: Rajat Bose

Rajat Bose of recommends buying Aurobindo Pharma and Snowman Logistics.
 Money Control4 days ago Like Aurobindo Pharma, buy BPCL: Prakash Gaba  Money Control4 weeks ago Buy Aurobindo Pharma, HDFC: Rajat Bose  Money Control4 weeks ago BoAML retains buy on Aurobindo, sees 23% EPS CAGR over FY16-18  Money Control1 month ago

Aurobindo Pharma Q2 PAT seen up 5.8% to Rs 617.3 cr: Centrum

Net Sales are expected to increase by 5.9 percent Q-o-Q (up 18.4 percent Y-o-Y) to Rs 3945.3 crore, according to Centrum.
 Money Control3 days ago Aurobindo Pharma Q1 net up 24% at Rs 585 cr  Money Control4 weeks ago Aurobindo beats the pharma blues  Business Standard1 month ago Aurobindo Pharma gains on strong Q1 results  Business Standard1 month ago

Buy Aurobindo Pharma; target of Rs 970: Axis Direct

Axis Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 970 in its research report dated October 07, 2016.
 Money Control1 week ago Sell Aurobindo Pharma, target Rs 808 : Siddarth Bhamre  Economic Times2 weeks ago Buy Aurobindo Pharma Ltd. target Rs 965 : Dharmesh Shah  Economic Times2 weeks ago Buy Aurobindo Pharma Ltd., target Rs 900.0 : Kunal Bothra  Economic Times3 weeks ago
Financial Express

Aurobindo Pharma gets Buy rating from Jefferies; says best placed in segment to beat back challenges

Aurobindo has high earnings visibility with 25+ product launches (next six months), low product concentration and high approval rate. Aurobindo has high earnings visibility with 25+ product launches (next six months), low product concentration and ...
 Financial Express2 weeks ago Jefferies puts Buy rating on Aurobindo Pharma, here's why  Financial Express3 weeks ago

Buy IGL, Aurobindo Pharma; sell Mindtree: Ashwani Gujral

Ashwani Gujral of is of the view that one can buy IGL and Aurobindo Pharma and sell Mindtree.
 Money Control2 weeks ago Buy Yes Bank, Aurobindo Pharma, Bharat Forge: Sukhani  Money Control3 weeks ago Buy Aurobindo Pharma; sell ICICI Bank: Ashwani Gujral  Moneycontrol.com3 weeks ago Checkout: Reason why Tulsian likes Bharat Forge, Aurobindo  Money Control4 weeks ago

Stocks that must be on your radar

Some of the stocks that should be on your radar are: RBL Bank,Allahabad Bank,Orient Cement,UltraTech Cement,Aurobindo Pharma,Bharat Forge,GM Breweries,Chennai Petroleum Corporation,Mangalore Refinery and Petrochemicals,IDBI Bank.
 Money Control2 weeks ago Six in Sixty: Stocks you should keep on your radar  Money Control2 weeks ago Here's why Aurobindo, JSPL, YES Bank, NMDC are in focus  Money Control2 weeks ago Stocks to be on your radar: Tata Motors, Claris, Aurobindo  Money Control1 month ago

Intas trumps Aurobindo to bag Teva's UK assets for$764 million

MUMBAI: Closely held Ahmedabad drug maker Intas Pharmaceuticals has trumped larger domestic peer Aurobindo Pharma and Cinven, a London-headquartered private equity firm to acquire assets of Teva Pharmaceuticals in UK and Ireland for an enterprise ...
 Economic Times2 weeks ago Failure to win Teva asset good for Auro Pharma  Economic Times2 weeks ago Intas buys Teva assets for Rs 5,100 cr  Business Standard2 weeks ago Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club  Economic Times2 weeks ago

Buy Indian Oil, HPCL; Sell Aurobindo Pharma: Ruchit Jain

The Sensex and Nifty staged a correction on Thursday owing to selling pressure in banking, IT, pharma and auto stocks. Meanwhile, NDTV Profit spoke to Ruchit Jain, equity technical analyst with Angel Broking, to discuss trading strategies for ...
 NDTV2 weeks ago Buy Aurobindo Pharma, DHFL; sell Adani Port: Mitesh Thacker  Money Control3 weeks ago Buy Aurobindo Pharma, IOB; sell Jubilant Food: Mitesh Thacker  Money Control1 month ago Buy Aurobindo Pharma, Oil India; sell LT: Mitesh Thacker  Money Control1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - aurobindo
Get updated on latest news & your favorite topics right in your inbox!
More     Less